{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:25:37Z","timestamp":1776324337107,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"9523","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/s0140-6736(06)68656-x","type":"journal-article","created":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T11:16:36Z","timestamp":1147432596000},"page":"1657-1664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":362,"title":["Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial"],"prefix":"10.1016","volume":"367","author":[{"given":"Jean-Louis","family":"Bresson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Perronne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Gerdil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Saville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"H\u00f6schler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(06)68656-X_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa044021","article-title":"Probable person-to-person transmission of avian influenza A (H5N1)","volume":"352","author":"Ungchusak","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(06)68656-X_bib4","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3201\/eid1110.050644","volume":"11","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/S0140-6736(06)68656-X_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1473-3099(06)70364-4","article-title":"Development and evaluation of influenza pandemic vaccines","volume":"6","author":"Stephenson","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"suppl 5","key":"10.1016\/S0140-6736(06)68656-X_bib7","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/S0264-410X(02)00509-1","article-title":"Selection of influenza vaccine strains and developing pandemic vaccines","volume":"20","author":"Wood","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(06)68656-X_bib8","series-title":"Guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application (CPMP\/VEG\/4717\/03)","year":"2004"},{"key":"10.1016\/S0140-6736(06)68656-X_bib9","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(06)68656-X_bib10","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(03)15014-3","article-title":"Safety and antigenicity of whole virus and subunit influenza A\/Hong Kong\/1073\/99 (H9N2) vaccine in healthy adults: phase I randomised trial","volume":"362","author":"Stephenson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(06)68656-X_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00430-002-0147-9","article-title":"Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines","volume":"191","author":"Hehme","year":"2002","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/S0140-6736(06)68656-X_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2004.02.019","article-title":"Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A\/Duck\/Singapore\/97 vaccine","volume":"103","author":"Stephenson","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/S0140-6736(06)68656-X_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1473-3099(04)01105-3","article-title":"Confronting the avian influenza threat: vaccine development for a potential pandemic","volume":"4","author":"Stephenson","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S0140-6736(06)68656-X_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jviromet.2005.10.001","article-title":"Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test","volume":"132","author":"Meijer","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/S0140-6736(06)68656-X_bib15","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.vaccine.2004.08.054","article-title":"Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system","volume":"23","author":"Nicolson","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/S0140-6736(06)68656-X_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/biol.2000.0245","article-title":"A tritonX-100-split virion influenza vaccine is safe and fulfils the Committee for Proprietary Medicinal Products (CPMP) recommendations for the European Community for immunogenicity, in children, adults and the elderly","volume":"28","author":"Lina","year":"2000","journal-title":"Biologicals"},{"key":"10.1016\/S0140-6736(06)68656-X_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S0140-6736(06)68656-X_bib19","unstructured":"European Committee for Proprietary Medicinal Products. Note for guidance on harmonization of requirements for influenza vaccines, March 1997 (CPMP\/BWP\/214\/96). European Agency for the Evaluation of Medicinal Products, March 12, 1997."},{"key":"10.1016\/S0140-6736(06)68656-X_bib20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immungenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067360668656X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067360668656X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T23:54:11Z","timestamp":1758844451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014067360668656X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":16,"journal-issue":{"issue":"9523","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S014067360668656X"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(06)68656-x","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(06)68656-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(06)68657-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}